With respect to breast cancer and perhaps other obesity-related cancers such as colorectal cancer [37], the proliferative potential of IGFBP-2 may be countered by its role in obesity and adipocyte biology [38]. This evidence concerns the gene IGFBP2 and colorectal cancer.